Previous close | 74.10 |
Open | 74.20 |
Bid | 73.50 x 1000 |
Ask | 74.50 x 1100 |
Day's range | 73.54 - 74.30 |
52-week range | 48.35 - 74.39 |
Volume | |
Avg. volume | 6,304,783 |
Market cap | 108.94B |
Beta (5Y monthly) | 0.77 |
PE ratio (TTM) | 61.92 |
EPS (TTM) | 1.19 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 81.86 |
Neogen (NEOG) faces intense competition from companies ranging from small businesses to divisions of large multinational companies.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.